IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Vitamin Shoppe, Inc. and Encourages Investors with Losses to Contact the Firm

Khang & Khang LLP (the “Firm”) announces the filing of a securities class action lawsuit against Vitamin Shoppe, Inc. (“Vitamin Shoppe” or the “Company”) (NYSE: VSI). Investors who purchased or otherwise acquired shares between March 1, 2017 and August 6, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm in advance of the October 27, 2017 lead plaintiff motion deadline.

If you purchased Vitamin Shoppe shares during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.

According to the Complaint, throughout the Class Period, Vitamin Shoppe made false and/or misleading statements, and/or failed to disclose: that the Company’s retail segment was continuing to dramatically decline; that its ongoing “reinvention plan” had been unsuccessful and brought more than $168 million in goodwill impairment, and it was not properly recognizing that impairment charge; and that as a result of the above, the Company’s public statements were materially false and misleading at all relevant times. On May 10, 2017, Vitamin Shoppe released first quarter 2017 financial results that were lower than market expectations and slashed its fiscal 2017 guidance by 45%, yet claimed the “reinvention plan” was still succeeding. Following this news, the Company’s stock price fell dramatically. On August 9, 2017, the Company announced that it was taking a $168.1 million impairment charge on the goodwill being carried on its books associated with its retail segment, and that it would report a loss per share of $6.73. Also, citing “the potential increase in variability of the Company’s results due to the number of initiatives being launched in the back half of the year,” Vitamin Shoppe dropped its fiscal 2017 earnings per share guidance altogether. When this news was announced, the Company’s shares declined in value materially, which caused investors harm according to the Complaint.

If you wish to learn more about this lawsuit, or if you have any questions concerning this notice or your rights, please contact Joon M. Khang, Esquire, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170901005786/en/